Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center
Clinical trial NCT01510626 · COMPLETED
Trial details
- NCT number
- NCT01510626
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-04-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.